| 68Ga | 68Gallium |
| 18F | 18Fluorine |
| 18F-FCH | 18F-fluorocholine |
| 18F-FDHT | 18F-fluordihydrotestosterone |
| 18F-NaF | 18F-sodium fluoride |
| ADT | androgen-deprivation therapy |
| AR | androgen receptor |
| BCR | biochemical recurrence |
| BS | bone scintigraphy |
| CRPC | castration-resistant prostate cancer |
| CT | computed tomography |
| DRE | digital rectal examination |
| EAU | European Association of Urology |
| ECOG | Eastern Cooperative Oncology Group |
| GG | Grade Group |
| GS | Gleason Score |
| HR | hazard ratio |
| ISUP | International Society of Urological Pathology |
| mHSPCa | metastatic hormone-sensitive prostate cancer |
| MRI | magnetic resonance imaging |
| OS | overall survival |
| PCa | prostate cancer |
| PET | positron emission tomography |
| PS | performance status |
| PSA | prostate-specific antigen |
| SAE | serious adverse events |
| TRUS | transrectal ultrasound |